Stephen Simpson, CFA
Long only, growth at reasonable price, value, research analyst

ChromaDex Looks Interesting, But Highly Speculative

The land of microcap stocks is not my preferred hunting ground; there are way too many hype-driven stories and way too few real diamonds in the rough to make the panning process worthwhile. Even so, ChromaDex (NASDAQ:CDXC) looks like a potential exception to the rule worthy of a closer look. I think the company's basic business strategy of pursuing high-potential ingredients for supplements and other nutritional products is a sound one. For better or worse, the pharmaceutical implications of some of these products could capture investor attention and really ignite the stock for stretches at a time.

All of that said, I won't go any further than to say this looks interesting and worthy of further investigation for...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details